Publications

Peer-reviewed articles, listed chronologically (most recent first). Names of co-corresponding authors are marked with *; co-first authors with . My name is highlighted.

2025

  1. Kim SC, Lee SA, Kim MJ, Shin YK, Kim HS, Jeong SY, Ku JL, Park JW. Pressurized intraperitoneal aerosol chemotherapy enhances cisplatin efficacy in colorectal cancer organoids. Sci Rep. 2025 Dec 19;15(1):44165.
  2. Kim CY, Kim SC, Shin R, Kim MJ, Jeong SY, Park JW, Ku JL. Integrative multi-omics of matched primary and liver metastatic colorectal cancer organoids identifies putative molecular targets. Transl Oncol. 2025 Nov 4;63:102592.
  3. Kim SC, Kim GH, Park JH, Lee KH, Koh J, Kim TY, Lee DW, Kim YJ, Kim S, Park SY, Min A, Shin YK, Im SA*, Ku JL*. Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models. Breast Cancer Res. 2025 May 1;27(1):66.
  4. Maeng JE, Kim JH, Kim SC, Yun WG, Kwon W, Han Y, Oh DY, Lee SH, Jang JY*, Ku JL*. Comprehensive molecular analysis of 26 newly established human pancreatic ductal adenocarcinoma cell lines reveals two clusters with variating drug sensitivities. Cancer Cell Int. 2025 Feb 19;25(1):53.
  5. Kim MJ, Song MH, Ji YS, Park JW, Shin YK, Kim SC, Kim G, Cho B, Park H, Ku JL*, Jeong SY*. Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model. Sci Rep. 2025 Jan 6;15(1):935.

2024

  1. Kim SC, Kim MJ, Park JW, Shin YK, Jeong SY*, Kim S*, Ku JL*. Effects of simulated microgravity on colorectal cancer organoids growth and drug response. Sci Rep. 2024 Oct 26;14(1):25526.
  2. Cho YE, Kim SC, Kim HJ, Han I, Ku JL*. Establishment and characterization of 18 Sarcoma Cell Lines: Unraveling the Molecular Mechanisms of Doxorubicin Resistance in Sarcoma Cell Lines. J Transl Med. 2024 Oct 2;22(1):889.
  3. Kim SC, Seo HY, Lee JO, Maeng JE, Shin YK, Lee SH, Jang JY*, Ku JL*. Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer. Cell Oncol (Dordr). 2024 Oct;47(5):1627–1647.
  4. Wang SS, Hall ML, Lee E, Kim SC, Ramesh N, Lee SH, Jang JY, Bold RJ, Ku JL, Hwang CI*. Whole-genome bisulfite sequencing identifies stage- and subtype-specific DNA methylation signatures in pancreatic cancer. iScience. 2024 Mar 4;27(4):109414.

2023

  1. Kim SC, Cho YE, Shin YK, Yu HJ, Chowdhury T, Kim S, Yi KS, Choi CH, Cha SH*, Park CK*, Ku JL*. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue. Sci Data. 2023 Jul 12;10(1):448.

2022

  1. Jeong N, Kim SC, Park JW, Park SG, Nam KH, Lee JO, Shin YK, Bae JM, Jeong SY*, Kim MJ*, Ku JL*. Multifocal organoids reveal clonal associations between synchronous intestinal tumors with pervasive heterogeneous drug responses. NPJ Genom Med. 2022 Jul 19;7(1):42.
  2. Song MH, Park JW, Kim MJ, Shin YK, Kim SC, Jeong SY*, Ku JL*. Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs. Biomed Pharmacother. 2022 Aug;152:113260.
  3. Seo HY, Kim SC, Roh WL, Shin YK, Kim S, Kim DW, Kim TM*, Ku JL*. Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types. Sci Rep. 2022 Apr 15;12(1):6345.
  4. Lee JH, Kim H, Lee SH, Ku JL, Chun JW, Seo HY, Kim SC, Paik WH, Ryu JK, Lee SK, Lowy AM, Kim YT*. Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies. Gut Liver. 2022 Jul 15;16(4):625–636.
  5. Kim SC, Park JW, Seo HY, Kim M, Park JH, Kim GH, Lee JO, Shin YK, Bae JM, Koo BK, Jeong SY*, Ku JL*. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Adv Sci (Weinh). 2022 Feb;9(5):e2103360.

2020

  1. Seo J, Lee CR, Paeng JC, Kwon HW, Lee D, Kim SC, Han J, Ku JL, Chae JH, Lim BC, Choi M*. Biallelic mutations in ABCB1 display recurrent reversible encephalopathy. Ann Clin Transl Neurol. 2020 Aug;7(8):1443–1449.
  2. Kim SC, Kim HS, Kim JH, Jeong N, Shin YK, Kim MJ, Park JW, Jeong SY*, Ku JL*. Establishment and characterization of 18 human colorectal cancer cell lines. Sci Rep. 2020 Apr 22;10(1):6801.

* Corresponding author(s). Equal contribution.